A systematic review of case-control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis
- PMID: 38831709
- DOI: 10.1111/ajd.14329
A systematic review of case-control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis
Abstract
Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions characterised by keratinocyte apoptosis, necroptosis and epidermal detachment. Several cytokines and cytotoxic proteins have been shown to be elevated in the blood and skin of SJS/TEN sufferers and biologics such as intravenous immune globulin and tumour necrosis factor (TNF)-alpha inhibitors have demonstrated good therapeutic potential. The exact pathogenic model of SJS/TEN however remains elusive. This systematic review aimed to evaluate the case-control studies of cytokines and cytotoxic proteins in the blister fluid and skin of adults with Stevens Johnson syndrome and/or toxic epidermal necrolysis. This review was registered with INPLASY and conducted in accordance with the PRISMA reporting guidelines. Potential bias was assessed using the NIH criteria. Eleven articles describing results from 96 cases and 170 controls were included. Fas, Fas ligand, Interleukin (IL)-8 and B-cell lymphoma (Bcl)-2 were elevated in SJS/TEN blister fluid and skin tissue, compared with healthy controls. IL-2, IL-6, TNF-alpha, tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), interferon-gamma and matrix metalloproteinase-2 were elevated in SJS/TEN blister fluid compared with fluid sampled from lesional controls. Granulysin, IL-33, TGF-beta-1 and IL-13 were elevated in SJS/TEN skin tissue compared with lesional lichen planus tissue, as was IL-13, IFN-gamma, IL-2 and IL-5, when compared with erythema multiforme tissue. A wide array of cytokines and cytotoxic proteins are present at higher concentrations in the blister fluid and skin tissue of SJS/TEN patients compared with healthy and lesional controls. Our findings suggest that these proteins may be pathogenic, as well as possibly markers for diagnosis, disease severity and course. They may also prove to be useful therapeutic targets. More research is needed.
Keywords: blister fluid; cytokines; gene expression; pathogenesis; skin tissue; stevens Johnson syndrome; toxic epidermal necrolysis.
© 2024 The Author(s). Australasian Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists.
Similar articles
-
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2. Cochrane Database Syst Rev. 2022. PMID: 35274741 Free PMC article.
-
Systematic review and meta-analysis of non-SCORTEN predictors of mortality in Stevens-Johnson syndrome and toxic epidermal necrolysis.Int J Dermatol. 2025 May;64(5):849-860. doi: 10.1111/ijd.17529. Epub 2024 Oct 24. Int J Dermatol. 2025. PMID: 39445692
-
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Current Management and Innovative Therapies.Int J Dermatol. 2025 Jul;64(7):1164-1172. doi: 10.1111/ijd.17768. Epub 2025 Apr 15. Int J Dermatol. 2025. PMID: 40231717 Review.
-
Improving Recruitment Through Social Media and Web-Based Advertising to Evaluate the Genetic Risk and Long-Term Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Community-Based Survey.J Med Internet Res. 2025 May 7;27:e63712. doi: 10.2196/63712. J Med Internet Res. 2025. PMID: 40334287 Free PMC article.
-
Photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification.Eur J Med Res. 2023 Jun 12;28(1):188. doi: 10.1186/s40001-023-01142-2. Eur J Med Res. 2023. PMID: 37303053 Free PMC article.
Cited by
-
Immune-related toxic epidermal necrolysis affecting trachea mucosal epithelium: a case report and literature review.Front Pharmacol. 2024 Oct 18;15:1454015. doi: 10.3389/fphar.2024.1454015. eCollection 2024. Front Pharmacol. 2024. PMID: 39494351 Free PMC article.
-
Recent developments in the research of Stevens-Johnson syndrome and toxic epidermal necrolysis: pathogenesis, diagnosis and treatment.Eur J Med Res. 2025 Jun 5;30(1):453. doi: 10.1186/s40001-025-02664-7. Eur J Med Res. 2025. PMID: 40474234 Free PMC article. Review.
-
The case for etanercept in the management of toxic epidermal necrolysis.Skin Health Dis. 2025 May 28;5(4):247-255. doi: 10.1093/skinhd/vzaf012. eCollection 2025 Aug. Skin Health Dis. 2025. PMID: 40755880 Free PMC article. Review.
-
Survival Following Steroid-Based Therapy in a Case of Penicillin-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap.Cureus. 2025 Jun 5;17(6):e85396. doi: 10.7759/cureus.85396. eCollection 2025 Jun. Cureus. 2025. PMID: 40621364 Free PMC article.
-
Updates in the pathogenesis of SJS/TEN.Allergol Int. 2025 Jul;74(3):361-371. doi: 10.1016/j.alit.2025.05.002. Epub 2025 Jun 4. Allergol Int. 2025. PMID: 40473510 Free PMC article. Review.
References
REFERENCES
-
- Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, et al. Comprehensive survival analysis of a cohort of patients with stevens‐Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013;133(5):1197–1204.
-
- Gibson A, Deshpande P, Campbell CN, Krantz MS, Mukherjee E, Mockenhaupt M, et al. Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. J Allergy Clin Immunol. 2023;151(2):289–300.e4.
-
- de Araujo E, Dessirier V, Laprée G, Valeyrie‐Allanore L, Ortonne N, Stathopoulos EN, et al. Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis. Exp Dermatol. 2011;20(2):107–112.
-
- Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, et al. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and stevens‐Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol. 2006;155(4):722–728.
-
- Sadek M, Iqbal O, Siddiqui F, Till S, Mazariegos M, Campbell E, et al. The Role of IL‐13, IL‐15 and Granulysin in the Pathogenesis of Stevens‐Johnson Syndrome/Toxic Epidermal Necrolysis. Clin Appl Thromb Hemost. 2021;27:1076029620950831. doi: 10.1177/1076029620950831
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous